Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Although multiple myeloma remains incurable outside of allogeneic hematopoietic stem cell transplantation, novel agents made available only in the last few decades have nonetheless tremendously improved the landscape of myeloma treatment. Lenalidomide, of the immunomodulatory class of drugs, is one...
Saved in:
| Main Authors: | S. A. Tuchman, N. J. Chao, C. G. Gasparetto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2012/712613 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Progress of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Myeloma
by: Ya-Nan Wang MS, et al.
Published: (2025-03-01) -
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
by: Seunghee Kim-Schulze, et al.
Published: (2024-04-01) -
UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01) -
UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01) -
Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)